NO960221D0 - 9-substituerte 2-(2-n-alkoksyfenyl)-purin-6-oner - Google Patents

9-substituerte 2-(2-n-alkoksyfenyl)-purin-6-oner

Info

Publication number
NO960221D0
NO960221D0 NO960221A NO960221A NO960221D0 NO 960221 D0 NO960221 D0 NO 960221D0 NO 960221 A NO960221 A NO 960221A NO 960221 A NO960221 A NO 960221A NO 960221 D0 NO960221 D0 NO 960221D0
Authority
NO
Norway
Prior art keywords
alkoxyphenyl
purin
substituted
Prior art date
Application number
NO960221A
Other languages
English (en)
Other versions
NO960221L (no
Inventor
Ulrich Niewohner
Erwin Bischoff
Helmuth Schutz
Elisabeth Perzborn
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO960221D0 publication Critical patent/NO960221D0/no
Publication of NO960221L publication Critical patent/NO960221L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO960221A 1995-01-19 1996-01-18 9-substituerte 2-(2-n-alkoksyfenyl)-purin-6-oner NO960221L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (2)

Publication Number Publication Date
NO960221D0 true NO960221D0 (no) 1996-01-18
NO960221L NO960221L (no) 1996-07-22

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960221A NO960221L (no) 1995-01-19 1996-01-18 9-substituerte 2-(2-n-alkoksyfenyl)-purin-6-oner

Country Status (30)

Country Link
US (1) US5866571A (no)
EP (1) EP0722943A1 (no)
JP (1) JPH08231546A (no)
KR (1) KR960029335A (no)
CN (1) CN1138583A (no)
AR (1) AR002704A1 (no)
AU (1) AU4097796A (no)
BG (1) BG61729B1 (no)
BR (1) BR9600149A (no)
CA (1) CA2167349A1 (no)
CO (1) CO4700524A1 (no)
CZ (1) CZ16896A3 (no)
DE (1) DE19501480A1 (no)
EE (1) EE9600020A (no)
FI (1) FI960226A (no)
HR (1) HRP960009A2 (no)
HU (1) HUP9600107A3 (no)
IL (1) IL116771A (no)
MA (1) MA23779A1 (no)
NO (1) NO960221L (no)
NZ (1) NZ280829A (no)
PE (1) PE10597A1 (no)
PL (1) PL312353A1 (no)
SG (1) SG47379A1 (no)
SK (1) SK7696A3 (no)
SV (1) SV1996000004A (no)
TN (1) TNSN96005A1 (no)
TR (1) TR199600701A2 (no)
YU (1) YU2896A (no)
ZA (1) ZA96399B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
AU8444401A (en) * 2000-09-06 2002-03-22 Tanabe Seiyaku Co Preparations for oral administration
AU2002230217B2 (en) * 2001-02-15 2005-02-17 Tanabe Seiyaku Co., Ltd. Tablets quickly disintegrated in oral cavity
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
BRPI0207215B8 (pt) * 2001-12-13 2022-11-01 Daiichi Suntory Biomedical Res Limited Derivados de pirazolopirimidinona tendo ação de inibição de pde7
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US20050154202A1 (en) * 2002-04-05 2005-07-14 Hagmann William K. Substituted aryl amides
US10300042B2 (en) 2014-06-23 2019-05-28 Celgene Corporation Apremilast for the treatment of a liver disease or a liver function abnormality

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
CN1138583A (zh) 1996-12-25
NO960221L (no) 1996-07-22
EE9600020A (et) 1996-08-15
IL116771A (en) 1999-06-20
CZ16896A3 (en) 1996-08-14
SK7696A3 (en) 1996-08-07
AR002704A1 (es) 1998-04-29
FI960226A0 (fi) 1996-01-17
PL312353A1 (en) 1996-07-22
BR9600149A (pt) 1998-01-06
TNSN96005A1 (en) 2005-03-15
SG47379A1 (en) 1998-04-17
TR199600701A2 (tr) 1996-08-21
SV1996000004A (es) 1997-02-19
AU4097796A (en) 1996-07-25
NZ280829A (en) 1998-04-27
EP0722943A1 (de) 1996-07-24
FI960226A (fi) 1996-07-20
CO4700524A1 (es) 1998-12-29
HU9600107D0 (en) 1996-03-28
MA23779A1 (fr) 1996-10-01
HRP960009A2 (en) 1997-12-31
ZA96399B (en) 1996-08-14
PE10597A1 (es) 1997-06-13
JPH08231546A (ja) 1996-09-10
CA2167349A1 (en) 1996-07-20
YU2896A (sh) 1999-03-04
HUP9600107A3 (en) 1999-06-28
US5866571A (en) 1999-02-02
HUP9600107A2 (en) 1997-05-28
DE19501480A1 (de) 1996-07-25
KR960029335A (ko) 1996-08-17
BG100291A (bg) 1996-07-31
IL116771A0 (en) 1996-05-14
BG61729B1 (bg) 1998-04-30

Similar Documents

Publication Publication Date Title
DE59510981D1 (de) Bohrfutter
DE69635106D1 (de) Guaninderivat
DE69612854D1 (de) Spannfutter
NO2009018I2 (no) Lasofoksifen
FI960226A (fi) 9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja
ATA135896A (de) Skibob
NO965549L (no) Omstillingsverktöy
DE69618742D1 (de) Schaltungsanordnung
DE69616610D1 (de) Spanndorn
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE69619622D1 (de) Schaltungsanordnung
ATE240972T1 (de) Cyclopeptolide
IT240472Y1 (it) Automotrice
ATA119896A (de) Scheibenmähwerk
DE59600405D1 (de) Gehhilfe
FI1943U1 (fi) Bomsystem till skogmaskin
FI1863U1 (fi) Vaeggkonstruktion till timmerhus
FI2196U1 (fi) Snoestyrningsblad till snoeslunga
FI2187U1 (fi) Hoerndetalj till plaottlaoda
FI2002U1 (fi) Haollare till spoestaell
FI950280A0 (fi) Smaeltsaekring till en brandsaekerhetsanordning
FI950433A0 (fi) Kapplingskrok till en lantbrukstraktors trepunktskoppling
FI950473A0 (fi) Vaeggkonstruktion till timmerhus
FI950830A0 (fi) Skaer till valskross
FI950851A0 (fi) Mekanism till kraftoeverfoeringsanordning